Pharmacological evaluation of bradykinin effect on human umbilical artery in normal, hypertensive and diabetic pregnancy

Pharmacological Reports

Volumn 59, Issue 1, 2007, Pages 64-73

  Radenković, Miroslav ^a   Grbović, Leposava ^a   Radunović, Nebojša ^a   Momčilov, Paja ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bradykinin; Gestational diabetes mellitus; Human umbilical artery; Pregnancy induced hypertension

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APAMIN; BRADYKININ; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; GLIBENCLAMIDE; ICATIBANT; INDOMETACIN; N(G) NITROARGININE; NIFEDIPINE; OUABAIN; OZAGREL; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE; TETRYLAMMONIUM BROMIDE; THROMBOXANE A2; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; FEMALE; HUMAN; HUMAN TISSUE; MATERNAL HYPERTENSION; PREGNANCY; PREGNANCY DIABETES MELLITUS; REGULATORY MECHANISM; SMOOTH MUSCLE; UMBILICAL ARTERY; VASOCONSTRICTION;

EID: 34047143300     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abbas F, Clayton JK, Marshall M, Senior J: Characterisation of kinin receptors on the human isolated umbilical artery. J Endocrinol, 1998, 156, 389-394.
2. Abbas F, Clayton JK, Marshall M, Senior J: Investigation into the role of cyclooxygenase products in the bradykinin response on isolated human myometrium and umbilical artery. Immunopharmacology, 1996, 33, 123-126.
3. Amamani S, Sangart B, Chaudhuri G: Eftects of selected endothelium-dependent vasodilators of fetoplacental vasculuture: physiological implications. Am J Physiol, 1999, 277, H842-H847.
4. American Diabetes Association: Gestational diabetes mellitus. Diabetes Care, 2003, 26, S103-S105.
5. Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A. Stamatelopoulos SF: Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care, 1998, 21, 2111-2115.
6. Arunlakshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol, 1959, 14, 48-58.
7. Boerma JI, Janzen KM, Oliveira L, Crankshaw DJ: Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol, 1999, 128, 1505-1512.
8. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science, 1992, 256, 532-535.
9. Cetin A, Kukner A. Ozturk F: Ultrastructure of human umbilical vessels in pre-eclampsia. J Matern Fetal Neonatal Med, 2002, 12, 178-184.
10. Félétou M, Martin CA, Molimard M, Naline E, Germain M, Thurieau C, Fauchere JL et al: In vitro effect of HOE 140 in human bronchial and vascular tissue. Eur J Pharmacol, 1995, 274, 57-11.
11. Gobeil F, Pheng LH, Badini I, Nguyen-Le XK, Pizard A, Rizzi A, Blouin D, Regoli D: Receptors for kinins in the human isolated umbilical vein. Br J Pharmacol, 1996, 118, 289-294.
12. +-A-TPase. Pharmacol Toxicol, 2003, 92, 265-271.
13. Izumi H, Garfield RE, Makino Y, Shirakawa, K, Itoh T: Gestational changes in endothelium-dependent vasorelaxation in human umbilical artery. Am J Obstet Gynecol, 1994, 170, 236-245.
14. Kenakin TP: Drug antagonism. In: Pharmacologic Analysis of Drug Receptor Interaction. Ed. Kenakin TP, Raven Press, Now York, 1997, 205-245.
15. Khalil RA, Granger JP: Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol - Regul Integr C, 2002, 283, R29-1145.
16. Klockenbusch W, Braun MS, Schroder H, Heckenberger RE, Strobach H, Schror K: Prostacyclin rather than nitric oxide lowers human umbilical artery two in vitro. Eur J Obstet Gynecol Reprod Biol, 1992, 47, 109-115.
17. Klockenbusch W, Goecke TW, Krussel JS, Tutschek BA, Crombach G, Schror K: Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia. Gynecol Obstat Invest, 2000, 50, 103-107.
18. Lekakis JP, Anastasiou EA, Papamichael CM, Stamatelopoulos KS, Dagre AG, Alevizaki MC, Stamatelopoulos SF: Short-term oral ascorbic acid improves endothelium-dependent vasodilatation in women with a history of gestational diabetes mellitus. Diabetes Care, 2000, 23, 1432-1434.
19. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY: Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens, 1999, 17, 1179-1187.
20. 2α. Gen Pharmacol, 1997, 29, 483-487.
21. Milesi V, Raingo J, Rebolledo A, Grassi de Gende AO: Potassium channels in human umbilical artery cells. J Soc Gynecol Investig, 2003, 10, 339-346.
22. Nelson M, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol, 1995, 268, C799-C822.
23. Pawlicka E, Bańkowski E, Jaworski S: Elastin of the umbilical cord arteries and its alterations in EPH gestosis (preeclampsia). Biol Neonate, 1999, 75, 91-96.
24. Persson A, Johansson K Jansson T, Powell TL: Na(+)/K(+)-ATPase activity and expression in syncytio-trophoblast plasma membranes in pregnancies complicated by diabetes. Placenta, 2002, 23, 386-391.
25. Quan A. Leung SWS, Lao TT, Man RYK: 5-Hydroxytriptamine and thromboxane A2 as physiological mediators of human umbilical artery closure. J Soc Gynecol Investig, 2003, 10, 490-495.
26. Regoli D, Allogho N, Rizzi A, Gobeil FJ: Bradykinin receptors and their antagonists. Eur J Pharmacol, 1998, 348, 1-10.
27. Regoli D, Rizzi A, Perron SI, Gobeil FJ: Classification of kinin receptors. Biol Chem, 2001, 382, 31-35.
28. Rosenfeld CR, Roy T, DeSpain K, Cox BE: Large-conductance Ca2+dependent K+ channels regulate basal uteroplacental blood flow in ovine pregnancy. J Soc Gynecol Investig, 2005, 12, 402-408.
29. Saldeen P, Olofsson P, Laurini RN: Signs of platelet activation, but not lipid peroxidation, in fetal blood associated with functional and structural umbilicoplacental lesions in pregnancies complicated by impaired glucose metabolism J Matern Fetal Neonatal Med, 2002, 12, 165-171.
30. Saldeen P, Olofsson P, Parhar RS, al-Sedairy S: Prostanoid production in umbilical vessels and its relation to glucose tolerance and umbilical artery flow resistance. Eur J Obstet Gynecol Reprod Biol, 1996, 68, 35-41.
31. Scalera F, Dittrich R, Beckmann MW, Beinder E: Effect of endothelin-1 on intracellular glulathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial calls. Eur J Clin Invest, 2002, 32, 556-562.
32. Schoner W: Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem, 2002, 269, 2440-2448.
33. Tiritilli A, El Habach T, Haury L, Duret JF: BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2. Methods Find Exp Clin Pharmacol, 2004, 26, 247-252.
34. Tsukahara Y, Itakura A, Ohno Y, Ando H, Mizutani S: Umbilical plasma kinimase I activity in fetal hypoxia. Horm Metab Res, 2003, 35, 583-587.
35. Vainio M, Riutta A, Koivisto AM, Maenpaa J: Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta Obstat Gynecol Scand, 2004, 83, 1119-1123.
36. Walsh SW, Yuping W: Deficient gluthatione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstut Gynecol, 1993, 169, 1456-1461.
37. Watkins MT, Patton GM, Soler HM, Albadawi H, Humphries DE, Evans JE, Kadowaki H: Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase. Biochem J, 1999, 344, 747-754.
38. 2 conditions. Can J Physiol Pharmacol, 1994, 72, 1171-1179.
39. Zhou P, Liu LM, Hu DY: Effect of nitric oxide-induced tyrosine phosphorylation of calcium-activated potassium channel alpha subunit on vascular hyporesponsiveness in rats. Clin J Traumatol, 2005, 9, 209-215.